Almost all men over 60 and women over 75 should be eligible for statins, according to a new analysis.
After examining guidance on which patients should be offered statin therapy, researchers calculated 11.8 million English adults are eligible for the cholesterol-lowering drugs.
https://www.theguardian.com/society/2017/aug/01/nearly-all-men-over-60-and-women-over-75-eligible-for-statins-analysis-suggests
Meanwhile this conclusion from a new study
Effect of Statin Treatment vs Usual Care on Primary Cardiovascular Prevention Among Older Adults
The ALLHAT-LLT Randomized Clinical Trial
Conclusions and Relevance No benefit was found when pravastatin was given for primary prevention to older adults with moderate hyperlipidemia and hypertension, and a nonsignificant direction toward increased all-cause mortality with pravastatin was observed among adults 75 years and older.
http://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2628971
After examining guidance on which patients should be offered statin therapy, researchers calculated 11.8 million English adults are eligible for the cholesterol-lowering drugs.
https://www.theguardian.com/society/2017/aug/01/nearly-all-men-over-60-and-women-over-75-eligible-for-statins-analysis-suggests
Meanwhile this conclusion from a new study
Effect of Statin Treatment vs Usual Care on Primary Cardiovascular Prevention Among Older Adults
The ALLHAT-LLT Randomized Clinical Trial
Conclusions and Relevance No benefit was found when pravastatin was given for primary prevention to older adults with moderate hyperlipidemia and hypertension, and a nonsignificant direction toward increased all-cause mortality with pravastatin was observed among adults 75 years and older.
http://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2628971